Výsledky vyhledávání - "Audrey Moniot"

Low Molecular Weight Heparin Treatment Patterns and Outcomes in Cancer Patients with Acute Venous Thromboembolism: A Nationwide Cohort Study in France

Autor: Mahé, Laurent Bertoletti, Gaelle Gusto, Nadia Quignot, Artak Khachatryan, Jose Chaves, Audrey Moniot, Ruth Mokgokong, Isabelle

Publikováno v: Cancers; Volume 15; Issue 11; Pages: 3011

Patients with cancer have an increased risk of developing venous thromboembolism (VTE) and an increased risk of death from VTE. Until recently, the standard of care for treatment of VTE in cancer patients was low molecular weight heparins (LMWH). To

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=multidiscipl::688c00842f5e8b11c9f5346395cfb61e

Zobrazit plný text záznamu

Plný text ve formátu HTML

Comparative Analysis of All-Cause Health Care Resource Utilization and Costs Among Venous Thrombosis Patients Without Cancer Prescribed Apixaban or VKAs in France

Autor: Ruth Mokgokong, Artak Khachatryan, Nadia Quignot, Jose Chaves, Audrey Moniot, Gaelle Gusto

Publikováno v: Advances in Therapy. 39:3766-3776

The direct oral anticoagulant (DOAC) apixaban has shown to have non-inferior efficacy and better safety than vitamin K antagonists (VKAs) in patients with venous thromboembolism (VTE). We determined whether healthcare resource use (HCRU) and direct a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3ca02e6eb462c6f5faae8607386b78f
https://doi.org/10.1007/s12325-022-02200-7

Zobrazit plný text záznamu

Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France

Autor: Laurent Bertoletti, Gaelle Gusto, Artak Khachatryan, Nadia Quignot, Jose Chaves, Audrey Moniot, Ruth Mokgokong

Publikováno v: Thrombosis and haemostasis. 122(8)

Introduction Data from clinical trials indicate that direct oral anticoagulants (DOACs) are noninferior and safer than conventional therapy (low-molecular-weight heparin followed by a vitamin K antagonist [VKA]) for treating venous thromboembolism (V

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e99c9402b9c2c11c949382dcf6a632b
https://pubmed.ncbi.nlm.nih.gov/34983073

Zobrazit plný text záznamu

Anticoagulant Treatment Patterns and Outcomes in Patients with Venous Thromboembolism and Active Cancer - a Nationwide Cohort Study in France

Autor: G Gusto, Ruth Mokgokong, Artak Khachatryan, José Chaves, Laurent Bertoletti, Audrey Moniot, Nadia Quignot

Publikováno v: Blood. 138:670-670

BACKGROUND: Cancer is a major risk factor for venous thromboembolism (VTE) and for all-cause mortality following a VTE event. Higher risk can be attributed to certain cancer types and to metastatic disease. Until recently the gold standard for VTE an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fcab64c4568958fb1259a4c1cd834eea
https://doi.org/10.1182/blood-2021-147748

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání